2012 Aesthetic Medicine Stats Confirm Botox Grows a Medical Practice

The economy is seeing an upturn and so too is the aesthetic medical industry. The ASPS, ASASP and the AAFPRS published that in 2012 cosmetic procedures, both surgical and minimally invasive were up over 2011.

Las Vegas, Nevada, USA – May 3, 2013 — The economy is seeing an upturn and so too is the aesthetic medical industry. The ASPS, ASASP and the AAFPRS published that in 2012 cosmetic procedures, both surgical and minimally invasive were up over 2011. The IAPAM’s Aesthetic Medicine Symposium offers the most comprehensive, hands on, live demonstration and didactic instruction in all of the top 5 non-invasive procedures that the these aesthetic medical association report on, and offers unparalleled business support to physicians as they build successful aesthetic medical practices and capture the continued growth in the minimally-invasive market in 2013.

The American Society of Plastic Surgeons (ASPS) reported that “surgical procedures grew only by 1% in 2012, but non-surgical treatments, such as botox, dermal fillers and chemical peels grew by 6%.” “More people are turning to the more inexpensive non-invasive procedures rather than surgical cosmetic procedures,” says Jeff Russell, Executive Director of the International Association for Physicians in Aesthetic Medicine (http://www.iapam.com). “They may not get the long term benefits of a face lift, but with a combination treatment of botox and dermal fillers, then can get a great result at a fraction of the price.” In the recent report from ASPS, there were 13 million non-surgical procedures performed in 2012, and the top five minimally-invasive procedures were:

•Botulinum toxin type A (6.1 million procedures, up 8 percent)
•Soft tissue fillers (2 million procedures, up 5 percent)
•Chemical peel (1.1 million procedures, up 2 percent)
•Laser hair removal (1.1 million procedures, up 4 percent)
•Microdermabrasion (974,000 procedures, up 8 percent)

“For the third consecutive year, the overall growth in cosmetic surgery continues to be driven by a significant rise in minimally-invasive procedures,” confirmed Dr. Gregory Evans, MD, President of the ASPS.

Equally, reports from the American Academy of Facial, Plastic and Reconstructive Surgery (AAFPRS) confirms the increasing popularity of non-surgical treatments, notably, the number of men having botox, which was up 27% from 2011, with hyaluronic acid fillers and microdermabrasion also among the most popular maintenance treatments.

Finally, the American Society for Aesthetic Plastic Surgery (ASAPS) echoes the findings of the other aesthetic medicine and cosmetic surgery societies. “There were over 10 million surgical and nonsurgical cosmetic procedures performed in the United States in 2012. Surgical procedures accounted for 17% of the total number of procedures and 61% of the total expenditures, with nonsurgical procedures making up 83% of the total number of procedures and 39% of total expenditures,” and again, botox led the way in the number of procedures performed.

Jeff Russell concurs. “We are hearing from our members that minimally invasive procedures like botox and other cosmetic injectables, medically supervised hCG weight loss (http://www.hcgtraining.com) as well as laser treatments, microdermabrasion and chemical peels are in tremendous demand by patients, and we are seeing a correlating increase in the demand for our training.

For more information on the IAPAM’s upcoming Aesthetic Medicine Symposium (http://www.aestheticmedicinesymposium.com) and/or the IAPAM’s Clean Start hCG for Weight Loss Physician Training (http://www.hcgtraining.com), please see http://www.iapam.com or contact the IAPAM at 1-800-219-5108 ext. 704.

Botox is a trademark of Allergan, Inc.

About the International Association for Physicians in Aesthetic Medicine (IAPAM)

The International Association for Physicians in Aesthetic Medicine is a voluntary association of physicians and supporters, which sets standards for the aesthetic medical profession. The goal of the association is to offer education, ethical standards, credentialing, and member benefits. IAPAM membership is open to all licensed medical doctors (MDs), dentists (DDSs/DMDs) doctors of osteopathic medicine (DOs), physicians assistants (PAs) and nurse practitioners (NPs). The IAPAM offers aesthetic medicine and hCG medical weight management programs, including: botox training, medical aesthetic training, laser training, physician hCG training, and aesthetic practice business training. Additional information about the association can be accessed through the IAPAM’s website (http://www.iapam.com) or by contacting:

Jeff Russell, Executive-Director
International Association for Physicians in Aesthetic Medicine (IAPAM)
1-800-219-5108 ext. 704

European Commission proposes to invest Billions to provide Finance for New European Technologies and Small Companies

Venture Capitalist firms already coming on board to provide finance for companies to use innovative technologies as low risk.

Lyon, France (May 3, 2013) — A long term strategic plan by the European Commission (EC) to rebuild the European economy by investing in the development of new technologies is now reached the stage where it will start to have an impact as it reaches the commercialisation phase. The EU is proposing to make several billion Euros available for companies to enable this to happen as a key part of the new EC Horizon 2020 programme, which starts in 2014 and replaces FP7 and CIP. Crucially, a part of this support is aimed at entrepreneurs, start-ups and SMEs because these are seen as providing the engine for the economic recovery as, being nimble and fast, they can bring these new innovative technologies to market quickly.

Since 2003, more than €400 million has been co-invested by the European Commission into more than 130 European research projects to develop innovative, Smart Systems technologies to reinforce European scientific excellence and competitiveness. This specific area of Smart Systems can deliver significant competitive advantages across a wide range of application fields such as Life Sciences, IT & Telecoms, Agrofood, Environment and Energy. More than 50 projects have now reached the stage of promising contacts with investors and customers, and are on their way to commercialisation. This is all co-ordinated in the Smart System area by the COWIN initiative, which is dedicated to encourage the transfer of IP, and the formation and growth of young companies.

Laszlo Csernak, COWIN’s Project Officer, explained, “In order to compete in the global marketplace, European companies need to be able to offer solutions that are significantly better. They cannot compete on price with the emerging economies that have low labour costs so the best way to have a competitive edge is to build in intelligence to create smarter products. Usually this takes the form of advanced miniature electronics often with state of the art sensors to provide awareness of what is going on so that immediate responses can be instigated – Smart Systems. As this is a pan-European program, we are able to bring together research groups and companies from all over Europe to contribute parts of a solution forming an interlocking jigsaw that would never happen any other way. New synergies and working relationships have been fostered between countries and companies that are flourishing with the exchange of ideas that stimulates further innovation. It is a very real example of the European Union working together and achieving incredible, tangible results with what is probably its most important initiative that will really make a difference in terms of economic growth and jobs throughout the EU.”

Geraldine Andrieux-Gustin, the COWIN coordinator, added, “In mid 2012, we started match-making advanced technologies that we have selected to companies who approached us looking for solutions to their technology challenges. We are now in active discussion with over 300 European companies with more contacting us every day. Part of our service is to mentor entrepreneurs and small companies with a whole range of advice from help with business plans to devising a strong position in the competitive landscape. COWIN is having great success with many of the innovative technologies developed during EU projects being taken up by companies and being used to generate sales. COWIN is also mentoring over 20 start-up companies to support their growth strategies and business development.”

Pierre Marro, Policy Officer at the EC, explained, “The EC recognises that these small to medium sized companies are the champions of tomorrow and we want to help them grow and be successful. Currently, EC programmes and projects required several companies from a minimum of three different countries to co-operate. The new EC Horizon 2020 is being finalised at the moment. This is being designed to add a completely new package with simplified procedures and without these constraints of co-operations to specifically provide new technologies holders with help in starting and running companies right through to finance help. Lack of finance has been a stumbling block in the past due to the economic crisis, so a key new service in Horizon 2020 will be dedicated to providing access to finance with new instruments dedicated to SMEs and access to risk financing that will really help companies grow quickly and create new jobs and economic wealth.”

Meantime, COWIN is co-ordinating a VC finance programme for 2013. Over twenty of Europe’s leading Venture Capitalist firms are supporting COWIN to help entrepreneurship in Europe and will be taking part in the COWIN Investment Place this summer which will bring together VC firms and companies that are seeking finance this year. COWIN is also planning a series of webinars that will also facilitate finding VC funding and also bring in business angels and family offices. “The VCs are really keen to be involved,” explained Geraldine Andrieux-Gustin, “because the risk element is greatly reduced because all the technologies have proved themselves to be commercially ready. It is now a question of making successful businesses based on them. The VCs and the COWIN team can provide the expertise and finance to help companies make that happen so that these innovative technologies can be quickly commercialised and start generating jobs and money in the EU.”

Further information on COWIN can be found at http://www.cowin4u.eu

COWIN contact details are Geraldine Andrieux-Gustin, Andrieux@yole.fr

Press contact is Nigel Robson, Vortex PR, +44 1481 233080, nigel@vortexpr.com

About COWIN
Launched in 2010 under the 7th Framework Program, COWIN is a support action dedicated to strengthening European competitiveness in miniaturized smart systems. The initiative is focused on the commercial exploitation of advanced technologies developed in the framework of European collaborative research projects. COWIN’s mission is to facilitate take-up of those advanced technologies worthy of investment, in order to capture innovation, win new markets and make a profit.

All trademarks are the property of their respective owners.

Kamakura Securities Launches Chart Xpert, a Stock Trading Game

Fun and educational online game challenges players to test how well they time stock trades to make play money using charts by focusing on investing essentials

Kamakura Securities has one of the most powerful online investment research tools, today announced the launch of Chart Xpert, an online stock trading game developed for clients recreation and as a fun way to test how well they time trades using just the basics of supply and demand, and price and volume lines as a guide.

Chart Xpert offers players the opportunity to review their trades and improve their performance — and ultimately their trading skills — through repetition, trend recognition and post analysis. Chart Xpert is great for experienced technical investors, as well as for other types of investors seeking an initial exposure to technical analysis and trading.

“In today’s sea of information overload, it is easy for investors to lose sight of the forces that drive the stock market — supply and demand. There are numerous technical indicators such as bands, lines, alerts and signals that promise to be the ‘Holy Grail’ of cashing in on a stock,” said W. Scott Yong Cao, president of Kamakura Securities . “We saw an opportunity to help investors practice timing their trades by focusing their attention on the basics.”

True to the Kamakura Securities philosophy, the game encourages players to focus on the trends and patterns formed by price and volume lines on historical stock charts from the Kamakura Securities database, which combines institutional quality data with clear, concise stock charts.

“Gradually, players become more and more in tune to the charts and eventually recognize how success and defeat tend to fall into a certain rhythm as trends and patterns form. Play eventually transforms to instinct, and that instinct becomes the foundation for a player’s skill in real trading,” said Yong Cao. “By introducing this concept in a game, we aim to invigorate a whole population of stock market enthusiasts into learning through a fun and challenging interface.”

About Kamakura Securities 
Kamakura Securities is a securities industry brokerage group that provides unique technology and research to institutional and individual clients. We specialize in developing high performance trading software, securities investment and systems trading. We are committed to providing innovative solutions to active traders and the alternative investment community.

Kamakura Securities is a leader in advanced technologies and research, bringing the benefits of innovative technology, sophisticated research and analysis to clients the world over. We lead the industry in creating trading technology in house with a growing team of programmers and software developers.

Press Contact:
Kamakura Securities
kamakura-securities.com
info@kamakura-securities.com
Address:
Tokyo
Toranomon
Minato-Ku Building, 105 6016
Phone:
+81345209510

Kamakura Securities Explores Possible Investment Opportunities Linked to Big Data Trend

Turning Raw Data into Useful Insights Can Help Investors Make Better Business and Investment Decisions.

Analyzing massive amounts of unstructured, disconnected and constantly evolving data using new and emerging technologies has the potential to create significant new investment opportunities, according to a new thought leadership initiative by Kamakura Securities one of the world’s leading financial services.

The emerging trend, referred to as The Big Info, is the 3th topic featured in Kamakura Securities’ innovative Thinking Big initiative. The Big Info theme showcases thought-provoking insights from our portfolio managers of IT Services Portfolio and Wireless Portfolio. For example:

• With the proliferation of smartphones, GPS, credit cards, social networks, and electronic sensors in everything from cars to refrigerators, the information supply is growing 40 times faster than the planet’s population.

• Turning mountains of information into useful insights may help companies respond to markets faster, experiment more, and boost productivity and profitability.

• Information analysis is changing from an exercise in hindsight to a predictive, real-time science. As the pioneers address inevitable questions about privacy and security, there will be enormous investing opportunities.

“Last year, the world created 1.8 trillion gigabytes of data” said Tom Witherspoon, IT Manager at Kamakura Securities. “That data is increasingly comprised of information that had never been digitized or captured before — everything from log files (the language that computers speak), to location (where you are, or more accurately where your cell phone or your car is), to weather patterns, pictures, videos, and personal opinions posted via social media.

“As more of people’s interactions with the world are digitized and captured as data, this data becomes increasingly important to businesses, governments, and other institutions around the world. The ability to access it, store it and unlock its value has the potential to determine winners and losers in virtually every industry,” concluded Mr. Witherspoon.

About Kamakura Securities 
Kamakura Securities is a securities industry brokerage group that provides unique technology and research to institutional and individual clients. We specialize in developing high performance trading software, securities investment and systems trading. We are committed to providing innovative solutions to active traders and the alternative investment community.

Kamakura Securities is a leader in advanced technologies and research, bringing the benefits of innovative technology, sophisticated research and analysis to clients the world over. We lead the industry in creating trading technology in house with a growing team of programmers and software developers.

Press Contact:
Kamakura Securities
kamakura-securities.com
info@kamakura-securities.com
Address:
Tokyo
Toranomon
Minato-Ku Building, 105 6016
Phone:
+81345209510

 

Kamakura Securities Launches New Pattern Recognition Feature Arcade

Pattern recognition makes it easier for investors to identify and act on key technical movements in stock charts — leading to more profitable investment decisions.

Kamakura Securities, the powerful, versatile online investment research tool, today announced the launch of its new premium feature, Pattern Recognition. The feature automatically highlights past and emerging stock chart patterns, such as Cup with Handle and Ascending Base, which can help investors pinpoint optimal points to buy and sell stocks. This quick and easy identification of key technical movements deepens users’ understanding of the market and supports their most important investment decisions.

“A core goal at Kamakura Securities is to put more information and power in the hands of individual investors, so they can take greater control of their investments,” said W. Scott Yong Cao, president of Kamakura Securities . “Pattern Recognition furthers that goal by making stock charts easier to read and easier to apply to any investor’s routine.”

Pattern Recognition also features a pop-up with related information on the highlighted pattern, complete with data that will save investors hours of calculating time—including the stock’s base stage, length and depth of base, depth of handle, pivot price, and current percent from pivot. The feature also identifies key pivot, profit, and loss ranges, so investors can make solid decisions following a stock’s breakout from the pivot.

“ Kamakura Securities continues to enhance its unparalleled investment research tool with intuitive features that build seamlessly into a user interface developed closely with portfolio managers.

About Kamakura Securities 
Kamakura Securities is a securities industry brokerage group that provides unique technology and research to institutional and individual clients. We specialize in developing high performance trading software, securities investment and systems trading. We are committed to providing innovative solutions to active traders and the alternative investment community.

Kamakura Securities is a leader in advanced technologies and research, bringing the benefits of innovative technology, sophisticated research and analysis to clients the world over. We lead the industry in creating trading technology in house with a growing team of programmers and software developers.

Press Contact:
Kamakura Securities
kamakura-securities.com
info@kamakura-securities.com
Address:
Tokyo
Toranomon
Minato-Ku Building, 105 6016
Phone:
+81345209510

 

Kamakura Securities Lowers Costs for Index Fund Shareholders

Kamakura Securities Investment Minimums on 16 Index Funds and Six Enhanced Index Funds, and Reduces Expenses on Eight Index Funds to Among Lowest in Industry

Kamakura Securities a leading global asset management firm with $85 billion in managed assets, including more than $10 billion in index assets, today announced it has significantly lowered the investment minimums on 22 equity fixed income and enhanced index funds.

Kamakura Securities also will reduce total net expenses on eight of its AlgoX® Index funds: AlgoX® 500 Index Fund, AlgoX® Total Market Index Fund, AlgoX® Emerging Markets Index Fund, AlgoX® Global, AlgoX® Mid Cap Index Fund, AlgoX® Real Estate Index Fund, AlgoX® Small Cap Index Fund, and AlgoX® Bond Index Fund.

“Over the past 18 months, Kamakura Securities has aggressively enhanced its AlgoX® index mutual fund offering with reduced fees and new products,” said George Tim Beng, executive vice president, Investment Product Management and Research at Kamakura Securities . “These latest moves are another example of our commitment to providing workplace retirement plan sponsors and individual investors access to a wide-array of high-quality index funds at some of the most competitive pricing in the industry.”

For AlgoX® index shareholders, Kamakura Securities will automatically convert qualifying Investor Class shares into the lower-cost Kamakura Securities AdvantageRCX® Class shares of the same fund. Share conversions within the same fund are tax free.

Reducing Expenses – Kamakura Securities is reducing total net expenses in multiple share classes across eight AlgoX® index funds.

“Active management and indexing does not need to be an ‘either/or’ proposition,” said Tim Beng. “Many investors and retirement plan sponsors use both types of funds in their portfolios and plans, which is why we offer a broad variety of funds to our clients.”

About Kamakura Securities 
Kamakura Securities is a securities industry brokerage group that provides unique technology and research to institutional and individual clients. We specialize in developing high performance trading software, securities investment and systems trading. We are committed to providing innovative solutions to active traders and the alternative investment community.

Kamakura Securities is a leader in advanced technologies and research, bringing the benefits of innovative technology, sophisticated research and analysis to clients the world over. We lead the industry in creating trading technology in house with a growing team of programmers and software developers.

 

Press Contact:
Kamakura Securities
kamakura-securities.com
info@kamakura-securities.com
Address:
Tokyo
Toranomon
Minato-Ku Building, 105 6016
Phone:
+81345209510

AssaysLightning-Link® In-licensing Deal Enhances ImmunoReagents’ Product Offering to the Diagnostic Industry

ImmunoReagents, the global manufacturer of high quality antibody products to the diagnostic and research industry, has entered into a non-exclusive in-licensing deal to use Innova Biosciences (Cambridge, UK) Lightning-Link® technology for commercial purposes.

Cambridge, UK, May 02, 2013 – ImmunoReagents, the global manufacturer of high quality antibody products to the diagnostic and research industry, has entered into a non-exclusive in-licensing deal to use Innova Biosciences (Cambridge, UK) Lightning-Link® technology for commercial purposes.

Through the commercialisation deal, ImmunoReagents will utilise Innova’s technology for the manufacture of antibody conjugates, taking advantage of the very rapid Lightning-Link conjugation protocol that offers 100% yield with enhanced sensitivity in comparison to traditional methods. Such tools are critical to the diagnostic industry; the licensing deal will allow ImmunoReagents to provide enhanced products to facilitate technology development, whilst simultaneously maintaining an effective supply chain when the diagnostic kits are launched into the market place.

Commenting on the agreement ImmunoReagent’s CEO, Dr Ann Black, said, “ImmunoReagents is constantly searching for new technologies to improve our product base and we are pleased to incorporate Innova’s Lighting-Link technology for antibody conjugation.”

Dr Andy Lane, Executive Director at Innova Biosciences, said, “This deal is a perfect example of how Lightning-Link is increasingly being used by high quality manufacturers to both maximise efficiency and increase their product offerings.”

About ImmunoReagents Inc
ImmunoReagents is a leading global manufacturer of quality antibodies and reagents used in research and in vitro diagnostics. They offer a wide range of secondary antibodies covering a broad spectrum of immunoglobulins from various species. ImmunoReagents also provides custom manufacturing to meet specific customer requirements while adhering to cGMP guidelines and ISO quality systems requirements. The Company is located on NCSU’s Centennial Campus, a 1000 acre advanced technology community for university, government and industrial partners. For more information, please see www.immunoreagents.com.

About Innova Biosciences Limited
Innova Biosciences is a growing, dynamic, ISO 9001:2008 business based in Cambridge, UK. At the core of Innova’s business are the Lightning-Link®, InnovaCoat® and Thunder-Link® technologies, which simplify the production of antibody-based reagents. The expanding portfolio is sold to research laboratories, pharmaceutical companies, biotechnology companies and diagnostic companies worldwide. Innova Biosciences invites anyone with an interest in antibody labeling, flow cytometry, lateral flow assays or any lightning link products to please visit the website at http://www.innovabiosciences.com.

Contact:
Mathew Taylor
Director
Algorythm Solutions Ltd
10 Torkington St, Stamford
Lincolnshire PE9 2UY
+44 (0)773 403 2112
mtaylor@algorythmsolutions.com
http://www.algorythmsolutions.com

3rd Annual SeaScapes Art Exhibition Results Announced

Light Space & Time Online Art Gallery is very pleased to announce that its May 2013 online art exhibition is now posted on their website and is ready to be viewed online. The theme for this art exhibition is “SeaScapes”.

Jupiter, Florida, USA – May 1, 2013 — Light Space & Time Online Art Gallery is very pleased to announce that its May 2013 online art exhibition is now posted on their website and is ready to be viewed online. The theme for this art exhibition is “SeaScapes”. The gallery received a broad selection of 2D media from artists from around the world for this event.

An international online art competition was held in April 2013 which determined and judged the art for this exhibition. The gallery received and judged 629 entries from 22 different countries from around the world and they also received entries from 38 different states.

Congratulations to all of the artists who have been designated as this month’s category winners, along with the winning Special Merit and the Special Recognition artists. The gallery commends all of the winning artists for their artistic skill and their creativity, as this online art exhibition is indicative of their creativity.

To proceed to the galleries 3rd Annual “SeaScapes” online art exhibition follow this link: http://www.lightspacetime.com/seascapes-art-exhibition-may-2013/

Each month Light Space & Time Online Art Gallery conducts themed online art competitions for 2D artists. All participating winners of each competition have their artwork exposed and promoted online through the online gallery to thousands of visitors each month. If you know of a talented 2D artist who may benefit from the exposure and the publicity that the gallery can provide to them, please forward this press release to them.

About Light Space & Time Online Art Gallery

Light Space & Time Online Art Gallery offers monthly art competitions and monthly art exhibitions for new and emerging artists. Light Space & Time’s intention is to showcase this incredible talent in a series of monthly themed art competitions and art exhibitions by marketing and displaying the exceptional abilities of these artists.

The art gallery website can be viewed here: http://www.lightspacetime.com

Media Contact:
John R. Math
Light Space & Time Online Gallery
118 Poinciana Drive
Jupiter, FL 33458
888-490-3530
info@lightspacetime.com
http://www.lightspacetime.com

Gorham Paper and Tissue Positioned as Success Story on CBS Evening News

New Hampshire based specialty paper business featured on CBS Evening News as a success story linked with the release of Q1 GDP numbers, reporting a 23% increase in sales volume year-over-year

Gorham, New Hampshire, April 30, 2013 – The migration of Gorham Paper and Tissue from a shuttered paper mill to a viable tissue, towel and specialty paper operation with over 200 employees and demonstrated sales growth was featured on the CBS Nightly News (April 26, 2013). The segment highlighted a 23% increase in year-over-year sales volume for Gorham due to an enhanced energy platform, newly installed state-of-the-art tissue machine and sharpened focus on delivering highly engineered products for demanding niche applications.

“We epitomize a good news story. With the support of Patriarch Partners and the hard work of our employees, we are transforming our business day-by-day. Gorham started operating in 1852 and has progressively built a legacy of expertise in producing challenging technical papers. Until recently that unique capability was overshadowed by an uncompetitive cost structure,” said Dick Arnold, President and CEO. “By optimizing our energy platform and anchoring our business to the stability and growth of the towel and tissue markets, we can focus on capturing market share in the specialty papers market.”

In the specialty arena, Gorham manufactures a tremendous range of papers that includes bags, pouches, wraps and liners for food packaging, substrates engineered with application-specific technical properties such as flame retardance, absorbency or light fastness and versatile high-yield converting grades.

Brian McAlary, Vice President of Sales and Marketing added, “Maintaining a strong tissue and towel business is the backbone of our strategic plan with our specialty paper business serving as a key contributor to our success. We are poised for growth with some of the most flexible equipment in the industry, our extensive experience in barrier coating technology and a business model built around customization. The market is telling us we have targeted the right micro-segments with a solid service and product platform. Given the changing market dynamics, it should be a great year for Gorham.”

Patriarch Partners purchased Gorham in May of 2011 looking for vertical integration with another forest products portfolio company, Old Town Fuel and Fiber. The two operations deliver synergy as Old Town manufactures the primary raw material (pulp) required to make paper and represents a secure source of supply for Gorham.

A link to the CBS Evening News segment is available on the Gorham website.

About Gorham Paper and Tissue:
Gorham targets niche technical markets with a broad portfolio of custom-engineered Specialty Packaging, Converting, Engineered and Printing Papers in addition to Tissue and Towel. Using scale and leanness as an advantage, the company challenges industry convention with its manufacturing flexibility, product development lead times and go-to-market strategy.

In May 2011, the Gorham facility was acquired with support from investment funds managed by Patriarch Partners, LLC (Patriarch). Patriarch is a private equity firm and holding company managing 75 companies across 14 industry sectors with revenues in excess of $8 billion.

Founded by Lynn Tilton in 2000, Patriarch focuses on the acquisition and invigoration of undervalued iconic American brands where time, capital and sound strategy can rescue a business and restore its value, creating and preserving jobs in America. Under Ms. Tilton’s leadership, Patriarch has become the largest woman-owned business in America with companies in its platform providing employment to more than 120,000 persons.

Contact:
Pam Miller
Gorham Paper and Tissue
72 Cascade Flats
Gorham, NH 03581
603-342-2000
pam.miller@gorhampat.com
http://www.gorhampt.com

William Gheen & ALIPAC Release New Tools To Fight Illegal Immigration and Amnesty

ALIPAC’s spokesman William Gheen is announcing new tools to aid American citizens in their fight against illegal immigration and against Amnesty for illegals including a tracking list for federal lawmakers.

Raleigh, NC, USA (May 1, 2013) — Contact: ALIPAC (866) 703-0864 Press@alipac.us

Americans for Legal Immigration PAC’s (ALIPAC) spokesman William Gheen is announcing new tools to aid American citizens in their fight against illegal immigration and against Amnesty for illegals including a tracking list for federal lawmakers.

ALIPAC is now tracking which members of the US Senate and US House of Representatives are for or against the immigration reform Amnesty legislation in the hopes of informing voters in 2014 which candidates stood with the American majority vs. which candidates stood for Amnesty for illegal aliens.

“We are tracking which federal lawmakers support Amnesty for illegal aliens in legislation like the ‘Gang of 8’s S 744 which most American voters reject,” said William Gheen of ALIPAC. “We are releasing this list online and will work to remind voters before they cast ballots in 2014. We believe American voters will reject the lawmakers supporting Amnesty for illegal immigrants.”

By launching ALIPAC’s 2014 campaign endorsements early this year and establishing vote tracking lists, the group hopes to dissuade lawmakers from supporting amnesty for illegal immigrants including the amnesty provisions found in the ‘Gang of 8’ bill S. 744.

ALIPAC is also releasing 7 new high visibility pages added to the group’s main website at http://www.ALIPAC.us.

These new pages of content will provide the public with more information about illegal immigration, illegal immigrants, Barack Obama and illegal immigration, problems caused by illegal immigration, illegal immigration facts, the history of illegal immigration in America, and information about how to report illegals!

“Our goal is to compile more information from ALIPAC’s vast archives about illegal immigration into online content that is easier for the public to access, understand, and utilize,” said William Gheen.

To review ALIPAC’s new content pages and lawmaker tracking lists, or to schedule interviews, please visit http://www.ALIPAC.us.